[Translated article] Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis

Authors:
  • ESE. Serra-Baldrich
    E. Serra-Baldrich
  • LSL.F. Santamaria-Babí
    L.F. Santamaria-Babí
  • JSJ. Francisco Silvestre
    J. Francisco Silvestre

Abstract
No abstract available

This publication has 38 references indexed in Scilit: